Home

 

 

Latest Discussions

Member Spotlight

Latest Specialty News

  • Manny Johnson keeps catching himself rubbing a spot on the upper right side of his chest. Starting when he was a teenager, the 21-year-old from Boston depended on a port implanted there to ease his monthly blood transfusions for sickle cell disease, a genetic disorder that caused a stroke when he was three. But in November, six months after Johnson became the first patient to receive an experimental therapy aimed at curing his disease, the port that had become part of him — requiring special approval to play sports, used when he was excused from school for a day or two every month for treatments — was removed. Johnson hasn't needed a transfusion or had any symptoms since May.
  • Provider Renewal

    To ensure that providers stay current in their knowledge of safe chemotherapy and biotherapy administration, APHON requires approved providers to renew their status every three years. All providers with an expiration date of Dec. 31, 2018 are required to complete the renewal program to maintain their provider status. Renew early and save! Member December Price: $75 Visit the APHON website to learn more.
  • The APHON Program Planning Committee invites you to submit a proposal of the following to be considered for presentation at APHON’s 43rd Annual Conference and Exhibit: Half-Day Preconference Workshop Concurrent Session Paper Presentation Poster Presentation For more information on our abstract requirements and new portal user instructions, please visit the APHON website . Ready to submit? Get started! The deadline to submit is Jan. 22, 2019 at 11:59 p.m. CT.

APHON Events


Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Facebook Feed

Twitter Feed